Supriya Lifescience Company Description

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.

The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas.

It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit.

Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine.

The company was founded in 1987 and is headquartered in Mumbai, India.

Supriya Lifescience Limited

Country	India
Founded	1987
Industry	Biotechnology
Sector	Healthcare
Employees	448

Contact Details

Address: 207/208 Udyog Bhavan Mumbai, 400063 India
Phone	91 22 4033 2727
Website	supriyalifescience.com

Stock Details

Ticker Symbol	SUPRIYA
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE07RO01027
SIC Code	2834

Key Executives

Name	Position
Dr. Satish Waman Wagh	Founder, Executive Chairman and Whole Time Director
Smita Satish Wagh	Whole-time Director
Dr. Saloni Satish Wagh	Managing Director
Shivani Satish Wagh	Joint Managing Director
Balasaheb Gulabrao Sawant	Whole Time Director
Krishna Raghunathan	Chief Financial Officer
Dr. Shireesh Bhalchandra Ambhaikar	Technical Head
Dr. Sushanta Kumar Gouranga Mishra	Chief Scientific Officer
Prachi Sathe	Company Secretary and Compliance Officer
Dr. Prashant Baban Zate	Head of Corporate Quality Assurance and Regulatory Affairs